Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial med. app.

Exposure

• • 200 kHz
  • intermediate frequency
  • also other exposures without EMF
• • electric current application
  • therapeutic/medical device
• • co-exposure